REPL
REPL
NASDAQ · Biotechnology

Replimune Group Inc

$17.61
+0.22 (+1.27%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 13 87%
Hold 1 7%
Sell 1 7%
Price Target
Analyst Price Target +101.9% upside
Low Target $27.68
Average Target $35.55
High Target $47.36
Current Price $17.61
Current
$17.61
Target
$35.55
$27.68 $35.55 avg $47.36
Scenario Analysis
Bear Case
$27.68
57.2%
Low target
Base Case
$35.55
+101.9%
Avg target
Bull Case
$47.36
+168.9%
High target
Risk/Reward
3.0x
Favorable
Price in Context
52-Week High
$17.78
-1.0% from high
52-Week Low
$1.50
+1,074.0% from low
Target vs 52W High
$35.55
+99.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -10.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +116.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 35% $149.45 -38.1%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
Strong Buy 30 90% $142.91 -60.7%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -35.8%